Forbes -
3 Feb 2021 20:00

Bristol Myers Squibb is scheduled to report its Q4 2020 results on Thursday, February 4. We expect the company to likely post revenue and earnings slightly below the consensus estimates, partly due to slowing sales growth rate of Opdivo. That said, Bristol Myers Squibb should see an overall pickup..
Share this Article
Comment on this Article
Please to comment